Showing results (131-140 of 1,098) with videos related to
Sort By:
Pageof 110
Metabolic Syndrome and Related Disorders|May 29, 2020
The Morbidity and Comorbidity of Nonalcoholic Fatty Liver Disease and Different Glucose Intolerance Strata in a Community-Based Chinese PopulationXiuying Zhang, Xianghai Zhou, Xueyao Han, et al.Journal of Proteome Research|August 25, 2009
Human serum metabonomic analysis reveals progression axes for glucose intolerance and insulin resistance statusesXiuying Zhang, Yulan Wang, Fuhua Hao, et al.Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|November 21, 2018
Correction to: Insulin Injection Technique in China Compared with the Rest of the WorldZhenqiang Song, Xiaohui Guo, Linong Ji, et al.Inflammopharmacology|March 19, 2025
The association between anti-inflammatory therapies and renal outcomes in patients with established cardiovascular disease or high cardiovascular risks: a meta-analysis of randomised controlled trialsWenfeng Yang, Zonglin Li, Chu Lin, et al.Frontiers in Pharmacology|December 9, 2022
Disparities in efficacy and safety of sodium-glucose cotransporter 2 inhibitor among patients with different extents of renal dysfunction: A systematic review and meta-analysis of randomized controlled trialsSuiyuan Hu, Chu Lin, Xiaoling Cai, et al.Diabetes & Vascular Disease Research|May 29, 2013
Individualized glycaemic targets and pharmacotherapy in type 2 diabetesClifford J Bailey, Pablo Aschner, Stefano Del Prato, et al.Neuro Endocrinology Letters|March 6, 2018
A pituitary abscess with one year follow-up after conservative treatment: A case reportNing Yuan, Sanbao Chai, Jianbin Sun, et al.Medicine|September 20, 2022
Reduction of C-reactive protein, low-density lipoprotein cholesterol, and its relationship with cardiovascular events of different lipid-lowering therapies: A systematic review and meta-analysis of randomized controlled trialsWenjia Yang, Xiaoling Cai, Chu Lin, et al.Journal of Diabetes|July 10, 2023
Sensitivity to thyroid hormone and risk of components of metabolic syndrome in a Chinese euthyroid populationFang Lv, Xiaoling Cai, Yufeng Li, et al.Frontiers in Endocrinology|July 30, 2026
Marked and reversible circulating insulin-like growth factor-1 elevation during teprotumumab N01 treatment for thyroid eye disease with limited correspondence to glycemic changesWei Zhao, Lingli Zhou, Ying Gao, et al.Pageof 110